Latest News about financial results
Recent news which mentions financial results
   Aurora Reports 20% YoY Uptick In Global Medical Marijuana, Expects Benefits From International Cannabis Regulatory Reforms
   
  
  
  June 20, 2024
  From Benzinga
 
   Marijuana Fintech Co. POSaBIT Reports 67% YoY Drop In Q1 Revenue, Renews Focus On Sustainable Profitability And Growth
   
  
  
  June 14, 2024
  From Benzinga
 From Benzinga
 
   Grown Rogue Reports Record Q1 Revenue, CEO Calls These Two States 'Primary Growth Drivers'
   
  
  
  May 30, 2024
  From Benzinga
 
   Entourage Health Cannabis Reports 9% YoY Increase In Q1 Revenue, Positive EBITDA And 'Substantial Growth'
   
  
  
  May 28, 2024
  From Benzinga
 From Benzinga
 
   California Cannabis Co. Gold Flora Reports 150% YoY Increase In Q1 Gross Profit, Trims Loss Sequentially
   
  May 15, 2024
  Tickers 
   NEWS
  
  
  From Benzinga
 From Benzinga
 
   Cannabis Company iAnthus Trims Net Loss In Q1, Reports YoY Increase In Revenue, Gross Profit
   
  
  
  May 14, 2024
  From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 
   CBD of Denver Reports YoY Increase In 2023 Gross Profit, Reduces Loss As It Continues To Expand Internationally
   
  
  
  May 02, 2024
  From Benzinga
 
   Revenue Growth And Cannabis Market Expansion: RIV Capital's Fiscal Highlights For 2023
   
  
  
  April 30, 2024
  From Benzinga
 
   Numinus Wellness Q2 2024 Revenue Declines Amid Clinic Reshuffling And Expected Industry Trends
   
  
  
  April 15, 2024
  From Benzinga
 
   International Expansion Drives Growth For This Canadian Cannabis Producer As It Reports Record Q1 Revenue
   
  
  
  April 15, 2024
  From Benzinga
 From Benzinga
 
   Female-Led California Weed Co. Gold Flora's Net Loss Grows In Q4, Reports YoY Increase In Revenue & Gross Profit
   
  
  
  April 05, 2024
  From Benzinga
 
   Lifeist Reports Highest Quarterly Gross Profit In History, Continues To Diversify Its Wellness Business
   
  
  
  April 02, 2024
  From Benzinga
 
   Cannabinoid-Based Products Maker Sees Triple-Digit Growth In 2023 Gross Profit, Revenue Surges 314% YoY
   
  
  
  April 02, 2024
  From Benzinga
 
   Atai Life Sciences Q4 And Full-Year 2023 Results: Steep Cash Drain Yet 2026 Target Remains, Update On Psychedelic Pipeline
   
  
  
  March 29, 2024
  From Benzinga
 
   Hemp-Focused Wellness Co. Moves Closer To Profitability, Reports Flat 2023 Revenue, Increase In Gross Profit
   
  
  
  March 28, 2024
  From Benzinga
 
   IM Cannabis' Q4 Revenue: Gross Profit Drops Due To Negative Impact Of Israel-Hamas War, Sees Germany As Growth Opportunity
   
  
  
  March 28, 2024
  From Benzinga
 
   This Cannabinoids-Focused Pharma Co. Sees 50% YoY Surge In Revenue In 2023, Trims Losses
   
  
  
  March 27, 2024
  From Benzinga
 
   Enveric Biosciences Optimistic On Q4 And Full-Year Results: 'Psychedelic-Inspired' Meds For Future Growth
   
  March 27, 2024
  Tickers 
   ENVB
  
  
  From Benzinga
 
   Body and Mind's Q2 Revenue Flat YoY, Narrows Loss By 94%
   
  
  
  March 26, 2024
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 


